CRUK

This page shows the latest CRUK news and features for those working in and with pharma, biotech and healthcare.

AZ and CRUK launch Cambridge genomics centre

The new partnership representation an expansion in its ambitions, and access to CRUK's world class functional genomics database will facilitate faster progress. ... AZ and CRUK will harness CRISPR tech to understand the biology behind cancer, leading to

Latest news

UK life sciences gets some Brexit relief with £1.3bn sector deal

CRUK is also pitching in with a £14m investment in a London unit for cancer biotherapeutics research and treatment, and other investments include a £20m pledge by GW Pharma and a
NICE lung cancer backing for Keytruda is biggest expansion yet

NHS. Prof Charles Swanton. Medical charity Cancer Research UK (CRUK) also welcomed the news.
CRUK forges £30m ‘post-Brexit’ R&D alliance

Another £5m project led by CRUK’s Beatson Institute in Glasgow – ARCCelerate – will concentrate on finding new ways to deliver personalised therapy for bowel cancers. ... No single organisation or country is going to beat cancer on its own,”
London cancer hub launched by Cancer Research UK

A key project will be investigating the impact of cancer progression on the immune system, says CRUK. ... TME. CRUK's Professor Charles Swanton. “We believe that, in the future, the biotherapeutics field will transform cancer care,” said CRUK’s
UK start-up Azeria emerges with £4m drug discovery pot for cancer

Boston and has been at the CRUK University of Cambridge lab since 2006, currently as a director of research.

More from news
Approximately 4 fully matching, plus 13 partially matching documents found.

Latest Intelligence

AstraZeneca: building a new ‘open innovation’ pharma company

MRC scientists are welcome to work in the building and our oncology staff are working in the CRUK Institute.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Experienced Medical Writers: Competitive Salary and Benefits

Principal Health Economist - North-West: Negotiable

Manager - Immunology, Therapeutic Area Communications & Publ...: Competitive Salary Offered

Business Director: Competitive Salary Offered

Senior Account Executive with progression to Account Manager, Me...: Excellent package

Medical Writer: Salary TBC

Systematic Reviewer - Oxford: Negotiable

Account Manager / Account Director: Competative

Account Director: Competitive Salary Offered

Digital Communications Lead, Healthcare Brand and Medical Commun...: up to £50K

Associate Director: £75, 000-90, 000

Medical (Scientific) Director: £120, 000 benefits

Medical Writer: Bonus Scheme, PTO &Private Healthcare

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Editorial Manager - MedComms: DOE

Associate Medical Director: Excellent PTO, bonus and 401k package

Account Manager / Senior Account Manager: 35, 000-40, 000

Healthcare Communications Account Directors x 2: Salary TBC

Account Manager- Healthcare Advertising: Negotiable

CALLING ALL SENIOR HEALTHCARE PR FREELANCERS!!!!! ACCOUNT DIRECT...: EXCELLENT DAY RATES AVAILABLE

Account Director – Healthcare Marketing – Berks: Salary TBC

Account Executive/ Senior Account Executive: competitive Salary Offfered

Account Manager: Negotiable

Senior Account Manager: Competitive Salary Offered

SAE – Healthcare PR – Award-Winning Consultancy: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Is China ready for a pharmaceutical gold rush?: Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance: Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis: Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...